Sign in
4

Changes in Ownership

Elanco Animal Health Inc Filed Acc 0001415889-24-011368

Options or other derivatives

  • PRESIDENT, CEO AND DIRECTOR acquired 213.84 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Simmons Jeffrey N · PRESIDENT, CEO AND DIRECTOR

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-04-19 Grant or award : show line 1 in the form Deferred Stock Units +213.84 $12.95 $2,769 1,438.28 D
Loading xslF345X05/form4-04232024_080437.xml…